Member Contact: Dr Joanne Boag
Position: Chief Executive Officer
Industry: Biotech & Pharmaceuticals
CTxONE Pty Ltd is an oncology small molecule drug development company. Our strategy centres on building a diversified portfolio of small molecule candidates that are highly differentiated and address yet unmet clinical needs in oncology. We work with research partners to identify suitable programs and build value in high potential drug discovery projects. CTxONE currently has one program that is out-licensed to Pfizer Inc. and is in the process of onboarding four early-stage projects from Australian medical research institutes and universities. CTxONE is a private company headquartered in Melbourne, Australia.